skip to main content

brainstorm askiatroX medicines

simulations beta

loading page…

learn & practise

exams international doctors free questions Socratic Tutor rounds stat clinical connections academy journal tool guides

clinical reference

askiatroX knowledge centre medicines UK / NICE guidance international guidance calculators q&a library

trust & support

how it works methodology account & support frequently asked questions about us clinical safety consultancy

legal

mobile app · scan to download

Medicines pimozideQuestion & answer

pimozide · Medicine question

Is pimozide contraindicated in patients with Parkinson's syndrome?

iatroX medicinesPublished 8 November 2026

The answer

Answer

Yes, pimozide (Orap) should not be used in patients with Parkinson's syndrome.

Sources for this answer

Orap 4 mg tabletsEUMEDICA SA · emc · SmPC §4.3 Contraindications · Version 2Document updated 20 March 2018

Sources checked 8 November 2026

Explore this learning need in CPDTake this topic to CPD, then choose your learning context and available question library.

The full medicine guide

pimozide

Read the wider context, including uses, precautions and the sources behind this medicine guide.

More questions about pimozide

What are the signs of neuroleptic malignant syndrome associated with pimozide?What is the elimination half-life of pimozide in patients with schizophrenia?Are any pharmaceutical incompatibilities known for Orap 4 mg pimozide tablets?By which route are Orap 4 mg pimozide tablets administered?Can pimozide affect the ability to drive or operate machinery?Can pimozide increase prolactin levels?

Read the pimozide guide

More clinical questions?

Explore the tools and reference material available on iatroX.

Explore askiatroX